KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 83 filers reported holding KRONOS BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,194,874 | -20.2% | 1,688,365 | +5.6% | 0.00% | – |
| Q2 2023 | $2,750,908 | +25.4% | 1,599,365 | +6.4% | 0.00% | – |
| Q1 2023 | $2,194,111 | -10.0% | 1,502,816 | -0.1% | 0.00% | – |
| Q4 2022 | $2,437,973 | -51.6% | 1,504,922 | +0.2% | 0.00% | – |
| Q3 2022 | $5,033,000 | -23.6% | 1,502,584 | -17.0% | 0.00% | – |
| Q2 2022 | $6,587,000 | -65.0% | 1,809,671 | -30.4% | 0.00% | – |
| Q1 2022 | $18,809,000 | -59.2% | 2,601,491 | -23.3% | 0.00% | -100.0% |
| Q4 2021 | $46,101,000 | -34.0% | 3,392,316 | +1.8% | 0.00% | -50.0% |
| Q3 2021 | $69,876,000 | -1.4% | 3,333,721 | +12.6% | 0.00% | 0.0% |
| Q2 2021 | $70,897,000 | +66.2% | 2,960,203 | +103.1% | 0.00% | +100.0% |
| Q1 2021 | $42,656,000 | +0.6% | 1,457,292 | +2.7% | 0.00% | 0.0% |
| Q4 2020 | $42,395,000 | – | 1,419,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $19,993,000 | 11.63% |
| Omega Fund Management, LLC | 3,818,283 | $27,606,000 | 5.65% |
| Nextech Invest Ltd. | 1,451,537 | $10,495,000 | 3.00% |
| Wildcat Capital Management, LLC | 1,438,232 | $10,398,000 | 2.66% |
| Artal Group S.A. | 1,542,954 | $11,156,000 | 0.47% |
| Perceptive Advisors | 2,421,142 | $17,504,000 | 0.35% |
| Alphabet Inc. | 1,438,232 | $10,398,000 | 0.34% |
| Casdin Capital, LLC | 583,436 | $4,218,000 | 0.19% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $3,814,000 | 0.19% |
| Samsara BioCapital, LLC | 78,131 | $565,000 | 0.14% |